质量体系的分析研究.pptx

上传人:A**** 文档编号:18816164 上传时间:2023-12-08 格式:PPTX 页数:39 大小:667.46KB
下载 相关 举报
质量体系的分析研究.pptx_第1页
第1页 / 共39页
质量体系的分析研究.pptx_第2页
第2页 / 共39页
质量体系的分析研究.pptx_第3页
第3页 / 共39页
质量体系的分析研究.pptx_第4页
第4页 / 共39页
质量体系的分析研究.pptx_第5页
第5页 / 共39页
质量体系的分析研究.pptx_第6页
第6页 / 共39页
质量体系的分析研究.pptx_第7页
第7页 / 共39页
质量体系的分析研究.pptx_第8页
第8页 / 共39页
质量体系的分析研究.pptx_第9页
第9页 / 共39页
质量体系的分析研究.pptx_第10页
第10页 / 共39页
质量体系的分析研究.pptx_第11页
第11页 / 共39页
质量体系的分析研究.pptx_第12页
第12页 / 共39页
质量体系的分析研究.pptx_第13页
第13页 / 共39页
质量体系的分析研究.pptx_第14页
第14页 / 共39页
质量体系的分析研究.pptx_第15页
第15页 / 共39页
质量体系的分析研究.pptx_第16页
第16页 / 共39页
质量体系的分析研究.pptx_第17页
第17页 / 共39页
质量体系的分析研究.pptx_第18页
第18页 / 共39页
质量体系的分析研究.pptx_第19页
第19页 / 共39页
质量体系的分析研究.pptx_第20页
第20页 / 共39页
亲,该文档总共39页,到这儿已超出免费预览范围,如果喜欢就下载吧!
下载资源
资源描述

质量体系的分析研究.pptx

《质量体系的分析研究.pptx》由会员分享,可在线阅读,更多相关《质量体系的分析研究.pptx(39页珍藏版)》请在冰点文库上搜索。

质量体系的分析研究.pptx

ImplementingaHolisticApproachtoyourQualityManagementSystem,StevenR.CagleV.P.ofMarketing&ProductDevelopmentSpartaSystems,Inc.,Agenda,SessionObjectivesQualityManagementSystemOverviewTraditionalChallengesRe-definingCAPAImplementingaQualityManagementSoftwareSolutionConclusionQ&A,2,SessionObjective,DiscusscriticalcomponentsofaneffectiveQualityManagementSystem(QMS),challengeswithcurrentsystems,andsolutionstoovercomethesechallengesbyimplementingaholisticQualityManagementSoftwaresolution.,3,GeneralIntroduction,DefiningCAPAISO13485:

2003,8.5.2CorrectiveActionCorrectiveactionsshallbeappropriatetotheeffectsofthenonconformitiesencountered.Adocumentedprocedureshallbeestablishedtodefinerequirementsforreviewingnonconformities(includingcustomercomplaints)determiningthecauseofnonconformitiesevaluatingtheneedforactiontoensurethatnonconformitiestonotrecurdeterminingandimplementingactionneeded,including,ifappropriate,updatingdocumentationrecordingoftheresultsofanyinvestigationandofactiontaken,andreviewingthecorrectiveactiontakenanditseffectiveness,5,DefiningCAPAISO13485:

2003,8.5.3PreventiveactionTheorganizationshalldetermineactiontoeliminatethecausesofpotentialnonconformitiesinordertopreventtheiroccurrence.Preventiveactionsshallbeappropriatetotheeffectsofthepotentialproblems.Itisalsodeterminepotentialnonconformitiesandtheircausesevaluatingtheneedforactiontopreventoccurrenceofnonconformitiesdeterminingandimplementingactionneededrecordingoftheresultsofanyinvestigationsandofactiontaken,andreviewingpreventiveactiontakenanditseffectiveness,6,QualityRegulation21CFR820.100,U.S.FoodandDrugAdministrationsregulationgoverningmedicaldevicemanufacturersqualitysystems:

(a)Eachmanufacturershallestablishandmaintainproceduresforimplementingcorrectiveandpreventiveaction:

analyzingprocesses,workoperations,concessions,qualityauditreports,qualityrecords,servicerecords,complaints,returnedproducts,andothersourcesofqualitydatatoidentifyexistingandpotentialcausesofnonconformingproduct,orotherqualityproblemsinvestigatingthecauseofnonconformitiesrelatingtoproduct,processes,andthequalitysystemidentifyingtheactionsneededtocorrectandpreventrecurrenceofnonconformingproductandotherqualityproblemsverifyingorvalidatingthecorrectiveandpreventiveactionImplementingandrecordingchangesinmethodsandproceduresneededtocorrectandpreventidentifiedqualityproblemsEnsuringthatinformationrelatedtoqualityproblemsornonconformingproductisdisseminatedtothosedirectlyresponsibleforassuringthequalityofsuchproductorthepreventionofsuchproblems;andSubmittingrelevantinformationonidentifiedqualityproblems,aswellascorrectiveandpreventiveactions,formanagementreview,7,QualityRegulation21CFR211.22,VerysimilaristheU.S.FDAsregulationforpharmaceuticalmanufacturers21CFRPart211.22(QualityControlUnit)responsibilitiesofaqualitycontrolunit.toassurethatnoerrorshaveoccurredor,iferrorshaveoccurred,thattheyhavebeenfullyinvestigated.Thequalitycontrolunitshallhavetheresponsibilityforapprovingorrejectingallproceduresorspecificationsimpactingontheidentity,strength,quality,anpurityofthedrugproductandinPart211.92(ProductionRecordReview)AnyunexplaineddiscrepancyorthefailureofabatchoranyofitscomponentstomeetanyofitsspecificationsshallbethoroughlyinvestigatedTheinvestigationshallextendtootherbatchesofthesamedrugproductandotherdrugproductsthatmayhavebeenassociatedwiththespecificfailureordiscrepancy.Awrittenrecordoftheinvestigationshallbemadeandshallincludetheconclusionsandfollow-up.,8,QuotesfromCurrentFDAWarningLetters,Eachmanufacturershallestablishproceduresforqualityauditsandconductsuchauditstoassurethatthequalitysystemisincompliancewiththeestablishedqualitysystemrequirementsandtodeterminetheeffectivenessofthequalitysystem.Qualityauditsshallbeconductedbyindividualswhodonothavedirectresponsibilityforthemattersandshallbetakenwhennecessary.Areportoftheresultsofeachqualityaudit,andreaudit(s)wheretaken,shallbemadeandsuchreportsshallbereviewedbymanagementhavingresponsibilityforthemattersaudited.Thedatesandresultsofqualityauditsandreauditsshallbedocumentedasrequiredby21CFR820.22.internalqualityauditsconductedbyyourfirmfailedtoverifythatthequalitysystemwaseffectiveinfulfillingqualitysystemobjectives(FDA483,Item#2).,9,QuotesfromCurrentFDAWarningLetters,Yourfirmfailstoimplementandmaintaincorrectiveandpreventiveaction(CAPA)proceduresthatincluderequirementsforanalyzingprocesses,workoperations,concessions,qualityauditreports,qualityrecords,servicerecords,complaints,returnedproduct,andothersourcesofqualitydatatoidentifyexistingandpotentialcausesofnonconformingproduct,orotherqualityproblemsasrequiredby21CFR820.100(a)

(1).Yourfirmfailstoestablishandimplementcorrectiveandpreventiveaction(CAPA)proceduresthatincluderequirementsforidentifyingtheaction(s)neededtocorrectandpreventrecurrenceofnon-conformingproductandotherqualityproblemsasrequiredby21CFR820.100(a)(3)Allactivitiesrequiredby21CFR820.100mustbeverifiedorvalidatedtoensurethatsuchactioniseffectiveanddoesnotadverselyaffectfinisheddevices,andtheresultsoftheseactivitiesshallbedocumentedasrequiredby21CFR820.100(a)(4)and(b).YourfirmsCAPAproceduresfailtodocumenthowanalysisisdoneandfailstorequireverification/validationthatCAPAdoesnotadverselyaffectfinisheddevices(FDA483,Item#8).,10,CommissionDirective2003/94/EC,PreambleHavingregardtotheTreatyestablishingtheEuropeanCommunity,Allmanufacturersshouldoperateaneffectivequalitymanagementsystemoftheirmanufacturingoperations,whichrequirestheimplementationofapharmaceuticalqualityassurancesystem.Article13-ComplaintsAnycomplaintconcerningadefectshallberecordedandinvestigatedbythemanufacturerArticle14-InspectionsThemanufacturershallconductrepeatedself-inspectionsinordertomonitortheimplementationandrespectofgoodmanufacturingpracticeandtoproposeanynecessarycorrectivemeasures.Recordsshallbemaintainedofsuchself-inspectionsandanycorrectiveactionsubsequentlytaken.,11,Morethanjustcorrectiveactions,CAPAismuchmorethanjust“correctiveactions”and“preventiveactions”.AnyopportunitytoimprovequalityinyourorganizationisaCAPA!

12,HolisticQMSDefinesCAPASources,Complaints,InternalInspections,SupplierAudits,RegulatoryAudits,Non-conformance,Deviations,OutofSpecification,OutofSpecification,AdverseTrends,AdverseEvents,IncomingInspections,Andmore,NumeroussourceareasforCAPAScopeof“problems”thatdriveCAPAsgobeyondnonconformingproductAnyprocessthataffectsproductqualityisincluded,13,CAPAProcessbestpractices,VerifyEffectiveness,ImplementActions,Review&ApprovePlan,Investigate,RootCause,ActionPlan,Identify&Triage,Regardlessofwheretheproblemoriginates,orwhattypeitis,itmustfollowaprocess,IdentifyproblemAssessimpactQuality/Regulatory/ManagementNotificationInvestigationProcess?

CompleteInvestigationDetermineRootCauseProposedCorrective/PreventiveActionsPlaneffectiveness,AssesschangesEnsurenoimpacttoproductqualityConsensusfromSMEsApproval,ImplementActionsVerifycompletedInformstakeholders,MeasuretoensureproblemhasbeenresolvedMonitortoensureitisnotre-occurring,ChangeControl,MetricsandReporting,14,AddressingQMSChallenges,TypicalQMSChallenges,ChallengesinProblemIdentificationMissingviewofthebigpictureLackofownershipandaccountabilityInabilitytolinkrelatedproblemsInsufficienttoolsfortrendingandanalysis,ChallengesinInvestigationQualityofinvestigationsispoorMissing&incompleteinformationInabilitytoeasilyreviewsimilarpastinvestigationsInconsistentinvestigationprocess&RootCauseNotdeterminingrootcausePastdueinvestigations,notbeingclosed,getlost,ProblemIdentification,Identify&InvestigateRootCause,CreateActionPlan,ChallengesinPlanningVaguerootcauseanalysisConfusionoverwhatis“corrective”andwhatis“preventive”actionInabilitytorelatecorrectiveactionstosourceproblemsLackofintegrationtoChangeControlSystem,16,TypicalQMSChallenges(cont.),VerifyEffectiveness,ImplementActions,ChallengesinImplementationNowaytotrackissuesthroughworkflowLackofvisibilitytoopenitemsLackofvisibilitytorelateditemsChangestoplanmid-streamCompliancerisk,ChallengesinEffectivenessEasyto“forget”tomeasureeffectivenessDifficulttogathernecessarymetricsNomeanstogeneratemetricsInabilitytomeasureeffectivenessdoesnotgiveusanyassuranceifweareaddressingtherootcauseoftheproblems,Review&ApprovePlan,ChallengesinReview&ApprovalNotsurewhoneedstoapproveApprovalsinserial,notparallelApprovalprocesstakeslongtimeLackofkeystakeholderinput,17,Solution,HolisticApproachtoQualityManagementGlobalize(harmonize)aroundacommonphilosophyandapproachtoCAPAandsourceEventsObtainfullcompliancewithcGxPs,aswellasregulatory&customerexpectationsUsequalitymetricsasabasisforcontinuousimprovementsTrendingProblemAnalysisThoroughInvestigationsandRootCauseAnalysisEnsuringCAPAeffectivenessBringattentiontoriskareastopreventproblemsImplementacentralizedQualityManagementSystem:

ManagesallinputsandoutputsaswellastheactualactionsScalabletobedeployedonaglobalbasisFunctionality/Flexibilitytomeetbusinessrequirements,18,Re-definingCAPA,Re-definingCAPA,DefinitionsStanda

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 初中教育 > 英语

copyright@ 2008-2023 冰点文库 网站版权所有

经营许可证编号:鄂ICP备19020893号-2